Sleep Solutions Business Deal was finalized on 5th March’2008 between Sleep Solutions Inc. and TPG Biotechnology. This deal ensured a huge inflow of fund amounting to US$ 20.5 million. This article would help the readers to get clear idea on the deal.
Sleep Solutions Business Deal – An Overview
Sleep Solutions Inc. has made a significant business deal with TPG Biotechnology which would ensure a fund inflow of US$ 20.5 million.
This fund would be used by Sleep Solution for innovating medical technologies for combating sleep disorders like Obstructive Sleep Apnea (OSA). Announcement of the final deal was done on 05.03.08.
Sleep Solutions Business Deal – Its Investors
The main investor of Sleep Solutions Inc is: –
TPG Biotechnology — made fresh investment through Fund II.
MedVenture Associates — existing investor
Lava Ventures — existing investor
Dr. Thomas Fogarty/Emergent Ventures — existing investor
Sleep Solutions, Inc. -Company Profile
It is a private company which manufactures technologically advanced medical equipments and devices for providing the following services:
Diagnosis of patients through direct-to-patient facility.
Sleep disorder therapy.
Prompt compliance to sleep disorders due to breathing problem (mainly Obstructive Sleep Apnea).
Provides cost-effective environment to both the doctors as well their patients for studying sleep disorders.
TPG Biotechnology – Company Profile
It is a venture capital investment firm, which invests primarily in such companies, which develop technologies in the following fields:
Obstructive Sleep Apnea – Market Overview
It is a chronic sleep disorder where the patient’s sleep gets disturbed due to breathing problem. More than forty million Americans suffer from this disease. Almost 5% of the total population of the world suffers from this disorder. But most of these cases remain unreported. According to an estimate, 80-90% of the entire OSA market all over the world still remains unexplored. In USA, this market is projected to grow at an annual rate of 20 to 30% in the coming 5 years. In the year 2008, diagnostic market of OSA is expected to cross the US$ 3 billion mark.
Sleep Solutions Business Deal – Future Game-Plan
Fund achieved through this deal would be utilized by Sleep Solutions Inc. for: –
Expanding sales as well as marketing capabilities.
Expansion of facilities
Continuation of development of its core products like
MediTrack(R) system for Patient Management and
NovaSom(R) QSG(R) medical equipment for diagnosing patients
Sleep Solutions Business Deal is destined to help the company in expanding its product base. Simultaneously, the acquired fund would help it to increase its market share through aggressive marketing.